Related Experiment Video
Updated: Mar 29, 2026

03:46
Author Spotlight: Coproparasitoscopic Examination of Dog Stools for Control and Prevention of Zoonotic Parasite Diseases
Published on: December 15, 2023
4.6K
Toxocariasis: A Review for Pediatricians
Dana M Woodhall1, Anthony E Fiore2
1Parasitic Diseases Branch.
Journal of the Pediatric Infectious Diseases Society
|December 2, 2015
Summary
Toxocariasis, a parasitic infection from pet roundworms, affects children in the US, causing organ and eye damage. Prevention involves hygiene, pet deworming, and proper waste disposal.
Area of Science:
- Veterinary Medicine
- Infectious Diseases
- Pediatrics
Background:
- Toxocariasis is a neglected tropical disease caused by Toxocara roundworms, commonly found in dogs and cats.
- It is endemic in the United States, posing significant health risks, particularly to children.
- The infection can lead to severe visceral or ocular complications affecting the lungs, liver, central nervous system, and eyes.
Purpose of the Study:
- To summarize the clinical manifestations, diagnosis, treatment, and prevention of toxocariasis.
Main Methods:
- Review of clinical syndromes: visceral and ocular toxocariasis.
- Discussion of diagnostic methods, including serologic testing.
- Outline of treatment options and preventive strategies.
Main Results:
- Visceral toxocariasis presents with symptoms like abdominal pain, cough, and wheezing.
- Ocular toxocariasis commonly causes vision loss and strabismus.
- Serologic tests detect antibodies but may not confirm active infection; treatment varies by syndrome.
Conclusions:
- Toxocariasis requires prompt diagnosis and appropriate treatment, with albendazole or mebendazole for visceral cases.
- Ocular toxocariasis management may involve corticosteroids, surgery, or antiparasitic drugs.
- Preventive measures include hygiene, pet deworming, and responsible pet waste disposal to reduce transmission.
Related Concept Videos
Toxidromes: Clinical Features
124
Toxidromes are specific patterns of symptoms resulting from toxic substance exposure. They help in the identification and treatment of poisoning. The symptoms of each toxidrome group indicate poisoning by a certain class of chemicals or drugs.1. Sympathomimetic: Stimulates the sympathetic nervous system. Symptoms include agitation, increased heart rate (HR), blood pressure (BP), respiratory rate (RR), temperature, and pupil size. Drugs like cocaine and amphetamines, along with tremors and...
124
Anthelminthic Agents
47
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
47
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
704
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
704
Pharmacokinetics in Pediatric Patients: Drug Excretion
373
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
373
Teratogenicity
4.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.5K
Allergic Reactions
33.6K
Overview
33.6K

